Valsartan reduced the vulnerability to atrial fibrillation by preventing action potential prolongation and conduction slowing in castrated male mice

2018 ◽  
Vol 29 (10) ◽  
pp. 1436-1443 ◽  
Author(s):  
Yi-Lin Sun ◽  
Peng-Hui Li ◽  
Ling Shi ◽  
Wan-Zhen Su ◽  
De-Sheng Li ◽  
...  

2009 ◽  
Vol 587 (5) ◽  
pp. 1087-1100 ◽  
Author(s):  
Ning Li ◽  
Valeriy Timofeyev ◽  
Dipika Tuteja ◽  
Danyan Xu ◽  
Ling Lu ◽  
...  


2018 ◽  
Vol 114 (suppl_1) ◽  
pp. S120-S120
Author(s):  
L Sartiani ◽  
L Sartiani ◽  
M Cameli ◽  
L Dini ◽  
S Modillo ◽  
...  






2009 ◽  
Vol 190 (1-6) ◽  
pp. 381-387 ◽  
Author(s):  
S. Bertil Olsson ◽  
Simion Cotoi ◽  
E. Varnauskas


2019 ◽  
pp. 333-345 ◽  
Author(s):  
Junaid Ahmed Bakhtiyar Zaman ◽  
Sanjiv M. Narayan ◽  
Michael R. Franz


2021 ◽  
Vol 16 (4) ◽  
pp. 1-9
Author(s):  
Helen Eftekhari

The article provides an overview of the principles in anti-arrhythmic drug prescribing. The cardiac action potential is explained, followed by general principles involved in treating arrhythmias and prescribing decisions. An overview of the five classifications of anti-arrhythmic drugs is given, with examples of the main drugs in the classification and principles to consider within each. Finally, anticoagulation is reviewed, being a cornerstone prescribing decision-making in the most common arrhythmia, atrial fibrillation.



Sign in / Sign up

Export Citation Format

Share Document